Abstract
Dr.O.P. Yadava, Editor-in-Chief, IJTC and Dr. V Bapat, Assistant Professor at Columbia University, New York, discuss issues related to slow development and uptake of transcatheter mitral valve replacement. Dr. Bapat stresses on the basic difference between transcatheter aortic and mitral valve interventions. He laments that issues related to mitral valve repair versus replacement and role of percutaneous MitraClip are still being hotly debated. He, however, is hopeful that technology shall evolve to make percutaneous options for secondary mitral regurgitation a viable proposition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wyler von Ballmoos MC, Kalra A, Reardon MJ. Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR). Ann Cardiothorac Surg. 2018;7:724–30.
Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23–32.
Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for seconday mitral regurgitation. N Engl J Med. 2018;379:2297–306.
Stone GW, Lindenfeld J, Abraham WT, et al."Transcatheter mitral-valve repair in patients with heart failure". N Engl J Med. 2018;379:2307–2318.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
(MP4 294,831 kb)
Rights and permissions
About this article
Cite this article
Yadava, O.P., Bapat, V. Transcatheter mitral valve therapies. Indian J Thorac Cardiovasc Surg 35, 520–521 (2019). https://doi.org/10.1007/s12055-019-00805-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-019-00805-2